Discovery by Fred Hutchinson Cancer Research Center’s Dr. Larry Corey and colleagues has implications for development of vaccine to prevent and treat HSV-2, similar infections
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method
Next-generation, high-speed DNA-decoding technology detects minimal residual disease in nearly double the number of leukemia patients than current gold standard method